ES2054759T3 - Procedimiento para la obtencion de inductores de parainmunidad. - Google Patents
Procedimiento para la obtencion de inductores de parainmunidad.Info
- Publication number
- ES2054759T3 ES2054759T3 ES88116529T ES88116529T ES2054759T3 ES 2054759 T3 ES2054759 T3 ES 2054759T3 ES 88116529 T ES88116529 T ES 88116529T ES 88116529 T ES88116529 T ES 88116529T ES 2054759 T3 ES2054759 T3 ES 2054759T3
- Authority
- ES
- Spain
- Prior art keywords
- inductors
- parainmunity
- procedure
- obtaining
- paramunization
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/15—Reoviridae, e.g. calf diarrhea virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
- A61K39/17—Newcastle disease virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/275—Poxviridae, e.g. avipoxvirus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/275—Poxviridae, e.g. avipoxvirus
- A61K39/285—Vaccinia virus or variola virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
- C12N2710/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24211—Parapoxvirus, e.g. Orf virus
- C12N2710/24234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24211—Parapoxvirus, e.g. Orf virus
- C12N2710/24261—Methods of inactivation or attenuation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
- C12N2760/18134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/948—Microorganisms using viruses or cell lines
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Mycology (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Abstract
LA PRESENTE PATENTE AFECTA A UN PROCESO PARA LA PRODUCCION DE INDUCTORES DE PARAMUNIDAD PARATIENDE DE DISTINTAS ESPECIES DE VIRUS, EL CUAL SE CARACTERIZA POR QUE, MEDIANTE UN TRATAMIENTO EN DOS NIVELES (ELEVACION DEL PH, CALENTAMIENTO CUIDADOSO) SE CONSIGUE UNA INACTIVACION DE LAS PARTICULAS VIRICAS REBAJANDO A LA VEZ LA ANTIGENIDAD, SIN QUE POR ELLO SE INFLUYA NEGATIVAMENTE EN LAS ACTIVIDADES PARAMUNIZADORAS DE LOS PREPARADOS CON VIRUS.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3735277 | 1987-10-17 | ||
DE3816139A DE3816139A1 (de) | 1987-10-17 | 1988-05-11 | Verfahren zur herstellung von paramunitaetsinducern |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2054759T3 true ES2054759T3 (es) | 1994-08-16 |
Family
ID=25860889
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES88116529T Expired - Lifetime ES2054759T3 (es) | 1987-10-17 | 1988-10-06 | Procedimiento para la obtencion de inductores de parainmunidad. |
Country Status (11)
Country | Link |
---|---|
US (1) | US5094850A (es) |
EP (1) | EP0312839B1 (es) |
JP (1) | JPH0813269B2 (es) |
KR (1) | KR0130775B1 (es) |
AU (1) | AU618287B2 (es) |
CA (1) | CA1338758C (es) |
DE (2) | DE3816139A1 (es) |
DK (1) | DK171798B1 (es) |
ES (1) | ES2054759T3 (es) |
IL (1) | IL88048A0 (es) |
NZ (1) | NZ226569A (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4405841C1 (de) * | 1994-02-23 | 1995-01-05 | Mayr Anton Prof Dr Med Vet Dr | Multipotente Paramunitätsinducer auf der Basis von Kombinationen von Pockenviruskomponenten, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
ES2099678B1 (es) * | 1995-11-03 | 1998-02-16 | Grifols Grupo Sa | Procedimiento para la inactivacion de virus en proteinas. |
WO1998009660A1 (en) * | 1996-09-06 | 1998-03-12 | Epic Therapeutics, Inc. | Viral inactivation of biological fluids with biomolecule activity retention |
HU227668B1 (en) * | 2000-07-11 | 2011-11-28 | Aicuris | Use of strains of the parapox ovis virus against organ fibrosis |
EP1499355A4 (en) | 2001-12-07 | 2005-10-05 | Bayer Pharmaceuticals Corp | USE OF PARAPOX B2L PROTEIN FOR THE TREATMENT OF CANCER AND THE MODIFICATION OF IMMUNE RESPONSES |
WO2007059821A1 (en) | 2005-11-24 | 2007-05-31 | Aicuris Gmbh & Co. Kg | Parapoxviruses in combination with classical cytotoxic chemotherapeutic agents as biochemotherapy for the treatment of cancer |
US9493744B2 (en) | 2012-06-20 | 2016-11-15 | Genentech, Inc. | Methods for viral inactivation and other adventitious agents |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1021133B (de) * | 1956-10-24 | 1957-12-19 | Dr Med Karl Theurer | Verfahren zur Herstellung von Impfstoffen gegen Viruserkrankungen |
EP0037441B1 (en) * | 1980-03-10 | 1984-05-09 | Seiji Arakawa | Pharmaceutical compositions useful as cellular immunopotentiator and anti-tumor agent, process for production thereof and microorganism used therein |
ATE36457T1 (de) * | 1983-05-02 | 1988-09-15 | Immuno Ag | Verfahren zur inaktivierung von vermehrungsfaehigen krankheitserregern. |
HU197517B (en) * | 1984-07-30 | 1989-04-28 | Laszlo Csatary | Process for production of terapeutical composition applicable against virus infection |
-
1988
- 1988-05-11 DE DE3816139A patent/DE3816139A1/de not_active Withdrawn
- 1988-10-06 DE DE8888116529T patent/DE3881326D1/de not_active Expired - Lifetime
- 1988-10-06 EP EP88116529A patent/EP0312839B1/de not_active Expired - Lifetime
- 1988-10-06 ES ES88116529T patent/ES2054759T3/es not_active Expired - Lifetime
- 1988-10-07 US US07/256,009 patent/US5094850A/en not_active Expired - Lifetime
- 1988-10-12 JP JP63255031A patent/JPH0813269B2/ja not_active Expired - Lifetime
- 1988-10-14 DK DK573888A patent/DK171798B1/da not_active IP Right Cessation
- 1988-10-14 NZ NZ226569A patent/NZ226569A/xx unknown
- 1988-10-14 IL IL88048A patent/IL88048A0/xx active Protection Beyond IP Right Term
- 1988-10-14 CA CA000580137A patent/CA1338758C/en not_active Expired - Fee Related
- 1988-10-14 KR KR1019880013396A patent/KR0130775B1/ko not_active IP Right Cessation
- 1988-10-17 AU AU23944/88A patent/AU618287B2/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
DK573888A (da) | 1989-04-18 |
KR890006254A (ko) | 1989-06-12 |
AU618287B2 (en) | 1991-12-19 |
JPH0813269B2 (ja) | 1996-02-14 |
IL88048A0 (en) | 1989-06-30 |
JPH02432A (ja) | 1990-01-05 |
US5094850A (en) | 1992-03-10 |
DK171798B1 (da) | 1997-06-02 |
EP0312839A2 (de) | 1989-04-26 |
CA1338758C (en) | 1996-12-03 |
EP0312839B1 (de) | 1993-05-26 |
DE3881326D1 (de) | 1993-07-01 |
KR0130775B1 (ko) | 1998-04-09 |
DE3816139A1 (de) | 1989-04-27 |
NZ226569A (en) | 1991-02-26 |
EP0312839A3 (en) | 1990-03-14 |
AU2394488A (en) | 1989-04-20 |
DK573888D0 (da) | 1988-10-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2127203T3 (es) | Vacunas y metodos para su produccion. | |
EA201792429A1 (ru) | Производные моно- или дизамещенных индолов в качестве ингибиторов репликации вирусов денге | |
CO2022010743A2 (es) | Sars-cov-2 desoptimizados y métodos y usos de los mismos | |
MX9403380A (es) | Inhibidores de proteasa de vih utiles para el tratamiento de sida. | |
EA201992329A1 (ru) | Замещенные производные индолина в качестве ингибиторов репликации вирусов денге | |
ATE475423T1 (de) | Immunostimulierende polynukleotide sequenzen zur verwendung bei der verhinderung und behandlung von viralen erkrankungen | |
ES2125251T3 (es) | Inhibidores de la proteasa del vih. | |
OA08724A (fr) | Treatment of human viral infections by dsRNA combined with viral inhibitors. | |
EA201992334A1 (ru) | Замещенные производные индолина в качестве ингибиторов репликации вирусов денге | |
NO980881D0 (no) | Fremgangsmåter og blandinger for selektiv modifikasjon av nukleinsyrer | |
DE60032795D1 (de) | Nordihydroguaiaretinsäurederivate zur behandlung von tumoren | |
EA202191764A1 (ru) | Замещенные оксопиридиновые производные | |
ES2054759T3 (es) | Procedimiento para la obtencion de inductores de parainmunidad. | |
SE9101815D0 (sv) | Behandling av sjukdom foerbunden med hiv-infektioner | |
EA202290024A1 (ru) | Способы лечения болезни фабри у пациентов с почечной недостаточностью | |
EA202092540A1 (ru) | Комбинации для лечения рака | |
BR112021022380A2 (pt) | Inibidores de jak | |
CO2021000914A2 (es) | Productos y métodos de virus adenoasociado recombinante para el tratamiento de la distrofia muscular de cinturas 2a | |
ES2174921T3 (es) | Inhibidores de la proteasa del vih. | |
ATE385807T1 (de) | Pharmazeutische verbindung und methoden zur behandlung von menschlichen karzinomen mittels arginin entzug | |
ATE78397T1 (de) | Verwendung von p-chlorophenoxyazetat von n,ndimethylbiguanidzur behandlung von neuropathien und nervendegeneration. | |
AR018260A1 (es) | Un proceso para preparar una solucion de gammaglobulina que puede ser administrada por via intravenosa, y solucion de gammaglobulina obtenida por dichoproceso | |
ES2113910T3 (es) | Procedimiento para la preparacion de un concentrado de trombina asegurado contra virus. | |
EA199800526A1 (ru) | Производные бензимидазола и их применение для лечения вирусных инфекций | |
DK1140113T3 (da) | Anvendelse af bisphosphonater til profylakse og behandling af infektiøse processer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 312839 Country of ref document: ES |